About the Advanced Regenerative Manufacturing Institute
Our mission is to advance the bioeconomy of the United States. The Institute’s work will positively impact not only manufacturing but also healthcare and education and workforce development for the nation.
Manufacturing scalability, process and partnership.
There are 400,000 people worldwide right now on waiting lists for organs. What if we could create lungs, livers or corneas at scale? It would be unprecedented.
Our goal is to move highly specialized regenerative medicine – engineering or regenerating human cells, tissues and organs – from lab to production to cure diseases and improve quality of life.
ARMI’s Leadership Team
DEAN KAMEN
Executive Director & Chairman of the Board, ARMI
Maureen Toohey
Deputy Executive Director & Secretary of the Board
Thomas Bollenbach, Ph.D.
Chief Technology Officer
Jim Scott
Chief Administrative Officer
Jennifer MacDonald, M.D.
Chief Operating Officer
News Highlights
Events
Meeting on the Mesa
Phoenix, AZ Phoenix, AZ, United StatesARMI | BioFabUSA will attend Meeting on the Mesa 2025, one of the premier partnering events for the cell and gene therapy sector, taking place October 6–8 in Phoenix, AZ.
2025 BioFab Investment Summit
Manchester, NH Manchester, New HampshireHosted by the BioFab Startup Lab, the 2025 BioFab Investment Summit connects early-stage companies with investors and partners driving regenerative medicine forward.
TERMIS-AM 2025
Detriot, MI Detroit, MI, United StatesARMI will present at TERMIS 2025, highlighting cutting-edge regenerative medicine research and its role in scaling biomanufacturing through national collaboration.
Defense Manufacturing Conference (DMC) 2025
Caribe Royale Orlando 8101 World Center Drive, Orlando, FL, United StatesBioFabUSA will exhibit and present at DMC 2025, sharing how scalable biomanufacturing can strengthen U.S. defense capabilities and support resilient manufacturing systems.
